title: [Effect of neovir in the treatment of acute hepatitis C].
abstract: Fifteen male patients with acute hepatitis C aged 16-44 years were treated with neovir, an interferon inducer, administered intramuscularly in a daily dose of 250 mg 2-3 times a week for 3 months. By the end of this therapy the RNA of hepatitis C virus could still be detected in 84.6% of the patients, the characteristics of ALT, AST and alkaline phosphatase exceeded the norm more than twofold. The results of neovir therapy are regarded as ineffective.
authors.affiliation: State Medico-Stomatological University, City Clinical Infectious Hospital No. 2, Central Research Unstitute of Epidemiology, Moscow, Russia.
authors.forename: S L
authors.initials: SL
authors.lastname: Maksimov
authors.forename: N D
authors.initials: ND
authors.lastname: Iushchuk
authors.forename: I M
authors.initials: IM
authors.lastname: Roslyĭ
authors.forename: A V
authors.initials: AV
authors.lastname: Kravchenko
authors.forename: T V
authors.initials: TV
authors.lastname: Danilova
mesh_terms: D000166:Acridines / Q000627:therapeutic use*; D000208:Acute Disease; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D008297:Male; D012367:RNA, Viral / Q000097:blood; D000637:Transaminases / Q000097:blood
chemical_list: D000166:Acridines; D007369:Interferon Inducers; D012367:RNA, Viral; C077681:Camedon; D000637:Transaminases